Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from IndonesiaCase Report Published on 2021-01-012023-06-19 Journal: International Journal of Infectious Diseases [Category] MERS, SARS, [키워드] Co-infection COVID-19 cross-reactivity Dengue Misdiagnosis Mixed-Infection. [DOI] 10.1016/j.ijid.2020.10.043 PMC 바로가기 [Article Type] Case Report
Microstructure, pathophysiology, and potential therapeutics of COVID-19: A comprehensive reviewCOVID-19의 미세구조, 병태생리학 및 잠재적 치료제: 종합 검토Review Published on 2021-01-012022-09-12 Journal: Journal of medical virology [Category] MERS, SARS, 진단, [키워드] 2019-nCoV 2019-nCoV infection ACE2 Affect against SARS-CoV Analysis angiotensin-converting enzyme 2 Antigen coronavirus COVID-19 cross-reactivity death developmental Diagnosis diagnosis of COVID-19 diagnostic disease domain drug Genetic variation genomic gold standard help higher risk HLA host-pathogen interaction individual Infection infections initial leukocyte MERS-CoV Microstructure Morphological Novel coronavirus pathophysiology polymerase chain RBD SARS-CoV sequence similarity serological test Seven severity spread of COVID-19 Stage the antibody the spike protein Trial understanding Vaccine vaccine candidate Variation virus whole protein [DOI] 10.1002/jmv.26254 PMC 바로가기 [Article Type] Review
High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa사하라 사막 이남 아프리카에서 중증 급성 호흡기 증후군 코로나바이러스-2(SARS-CoV-2)에 대한 기존 혈청학적 교차 반응의 높은 유병률Article Published on 2021-01-012022-09-11 Journal: International Journal of Infectious Diseases [Category] MERS, SARS, 진단, 치료기술, 치료법, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 Asia collected Coronavirus-2 correlated COVID-19 COVID-19 pandemic cross-protection cross-reactive cross-reactive antibodies cross-reactive antibody cross-reactivity death disease Europe evaluated exposure to HCoV HCoV-229E HCoV-NL63 HCoVs Human human coronavirus Hypothesis immunofluorescence assay in some incidence Infection morbidity and mortality MOST nucleocapsid protein Nucleocapsid proteins occurred other coronavirus other coronaviruses pandemic Pathogenesis plasma sample plasma samples pre-pandemic plasma sample Pre-pandemic plasma samples Prevalence prevalent Protein Recognition remained respiratory SARS-CoV-2 SARS-COV-2 infection serological serology Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus Significant significantly higher Spike proteins SSA sub-Saharan Africa tested the SARS-CoV-2 the spike protein USA [DOI] 10.1016/j.ijid.2020.10.104 PMC 바로가기 [Article Type] Article
HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID PatientsImmunology Published on 2020-12-232022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, [키워드] Anti-viral Antibody Response CD4+ cell CD4+ T cell CD4+ T cells CD8+ cell Cell characterized common variable immunodeficiency disorder (CVID) Coronavirus disease 2019 (COVID-19) correlation COVID-19 cross-reactive cross-reactivity CVID detectable Endemic evaluate evaluated Evidence Frequency had no HCoV-229E healthy control healthy individuals human endemic coronavirus 229E (HCoV-229E) human endemic coronavirus OC-43 (HCoV-OC43) IFNγ IL-2 Immunity less marker multifunctional nucleocapsid pathogen Patient patients patients with CVID peptide pools primary immunodeficiency (PID) profiles Protective Proteins provide raised reactive reactivity reported risk SARS-CoV-2 SARS-COV-2 infection Seven severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) severity T cell T cell response T cell responses TNFα virus [DOI] 10.3389/fimmu.2020.607918 PMC 바로가기 [Article Type] Immunology
Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell ImmunityCellular Response to Infection Published on 2020-12-212022-10-30 Journal: Journal of Virology [Category] COVID-19, MERS, [키워드] acute respiratory syndrome Analysis assays Assessing binding candidate CD8 Cellular immune response cellular response circulating conserved contribute Convalescent patients coronavirus coronavirus immunity Coverage COVID-19 vaccines Critical cross-reactivity Developing diagnostic tools disease effective Efficacy effort elicit elicited epitope exhibited highly networked/conserved T-cell epitope derived peptides HLA allele homology human coronavirus human coronaviruses identification identify Immunity immunogen immunogenic peptide immunoinformatics in silico novel coronavirus disease nucleocapsid nucleocapsid and spike proteins peptide Protein protein network Region response resulting SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2-specific immune response SARS-CoV-2-specific T-cell responses spike Spike proteins survivor T cell T-cell T-cell effector/polyfunctionality T-cell epitope T-cell immunity T-cell Response the SARS-CoV-2 to define Vaccine vaccine candidates variant Viral proteins viral variant [DOI] 10.1128/JVI.02002-20 PMC 바로가기 [Article Type] Cellular Response to Infection
COVID-19 with dengue shock syndrome in a child: coinfection or cross-reactivity?어린이의 뎅기 쇼크 증후군이 있는 COVID-19: 동시 감염 또는 교차 반응?Case Reports Published on 2020-12-212022-09-12 Journal: BMJ case reports [Category] MERS, SARS, 진단, [키워드] caused children clinical manifestation Coinfection Coma coma and raised intracranial pressure complicate country COVID-19 cross-reactivity Dengue shock syndrome disease disease entity Encephalitis Endemic enhanced Epidemics global health Health Infection Infectious disease Influenza Intensive International knowledge management outcome overlap paediatric intensive care raised Region researcher risk SARS-CoV-2 SARS-CoV-2 pandemic serological Spread syndrome tropical tropical medicine (infectious disease) unique virus [DOI] 10.1136/bcr-2020-239315 PMC 바로가기 [Article Type] Case Reports
Humoral Responses and Serological Assays in SARS-CoV-2 InfectionsSARS-CoV-2 감염의 체액 반응 및 혈청학적 분석Review Published on 2020-12-182022-09-11 Journal: Frontiers in Immunology [Category] MERS, SARS, 변종, 진단, 치료기술, [키워드] abundance acute respiratory disease antibody benefit Betacoronavirus Community coronavirus coronavirus 2 COVID-19 Critical cross-reactivity death detect develop Efficiency effort epidemiological expression levels Genetic variant genetic variants healthcare highlight humoral immune response humoral immune responses Humoral immunity Humoral response immune responses Immunity immunological implementation implication individuals knowledge limitation measure neutralization new strain novel Betacoronavirus original antigenic sin pandemic virus public health measure public health measures Reinfection respiratory Respiratory disease response resulting risk robust SARS-CoV-2 SARS-COV-2 infection seasonal coronaviruses serological Serological assay serological assays Serological testing serology stability Transmission dynamics vaccination Vaccine development virus Wuhan Wuhan, China [DOI] 10.3389/fimmu.2020.610688 PMC 바로가기 [Article Type] Review
Occurrence of Antibodies against SARS-CoV-2 in the Domestic Cat Population of GermanyArticle Published on 2020-12-172022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] acute respiratory syndrome antibody circulation close contact collected conducted coronavirus country COVID-19 cross-reactivity described diagnostics domestic cat ELISA felines Felis Germany Human human infection immunofluorescence incidence indicate Neutralizing antibodies Occurrence Population positive reactive risk SARS-CoV-2 screened sera Sero-prevalence serology serum sample serum samples Spread tested Transmission transmission of SARS-CoV-2 [DOI] 10.3390/vaccines8040772 PMC 바로가기 [Article Type] Article
Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity기능적으로 보존된 부위에 대한 SARS-CoV-2 항체의 교차 중화는 결합력에 의해 매개됩니다Article Published on 2020-12-152022-09-12 Journal: Immunity [Category] MERS, SARS, 진단, [키워드] ACE2 acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 angiotensin Angiotensin-converting enzyme angiotensin-converting enzyme 2 antibody Antibody avidity antibody COVA1-16 approach avidity bind binding block CDR CDR H3 complementarity-determining region conserved coronavirus coronavirus disease Coronavirus disease 2019 Coronavirus vaccines COVA1-16 COVID-19 cross-neutralization activity cross-neutralize cross-neutralizing cross-reactivity crystal structure domain driven by epitope epitope conservation Fab flexible functional IgG individual individual with COVID-19 Mediated MOST negative-stain electron microscopy neutralization overlap RBD RBS receptor respiratory SARS-CoV SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 RBD SARS-like coronavirus vaccine severe acute respiratory syndrome Coronavirus Site spike glycoprotein steric hindrance Structure the RBD the SARS-CoV-2 Therapies trimer Virus neutralization X-ray [DOI] 10.1016/j.immuni.2020.10.023 PMC 바로가기 [Article Type] Article
HCoV-NL63 and SARS-CoV-2 Share Recognized Epitopes by the Humoral Response in Sera of People Collected Pre- and during CoV-2 PandemicArticle Published on 2020-12-142022-10-29 Journal: Microorganisms [Category] COVID-19, [키워드] acute respiratory syndrome addition antibodies antibody Antibody Response Asymptomatic children competitive ELISA coronavirus COVID-19 cohort cross Cross reactivity cross-reactivity definitive diagnosis ELISA epitope Epitopes evaluated HCoV-NL63 Human incidence mild symptoms NL63 Older Patient patients peptides plasma sample protective immunity reduce reported response S protein epitope SARS-CoV-2 SARS-CoV-2 epitope severity significantly higher specific antibody the disease the timing was performed [DOI] 10.3390/microorganisms8121993 PMC 바로가기 [Article Type] Article